These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
97 related articles for article (PubMed ID: 23060561)
1. FBN2 methylation is detected in the serum of colorectal cancer patients with hepatic metastasis. Hibi K; Mizukami H; Saito M; Kigawa G; Nemoto H; Sanada Y Anticancer Res; 2012 Oct; 32(10):4371-4. PubMed ID: 23060561 [TBL] [Abstract][Full Text] [Related]
2. p16 Methylation is frequently detected in the serum of metastatic colorectal cancer patients. Hibi K; Mizukami H; Saito M; Kigawa G; Nemoto H Hepatogastroenterology; 2014; 61(130):354-6. PubMed ID: 24901139 [TBL] [Abstract][Full Text] [Related]
3. Detection of TFPI2 methylation in the serum of colorectal cancer patients. Hibi K; Goto T; Shirahata A; Saito M; Kigawa G; Nemoto H; Sanada Y Cancer Lett; 2011 Dec; 311(1):96-100. PubMed ID: 21820798 [TBL] [Abstract][Full Text] [Related]
4. Aberrant methylation of FBN2 in human non-small cell lung cancer. Chen H; Suzuki M; Nakamura Y; Ohira M; Ando S; Iida T; Nakajima T; Nakagawara A; Kimura H Lung Cancer; 2005 Oct; 50(1):43-9. PubMed ID: 15951052 [TBL] [Abstract][Full Text] [Related]
5. Detection of TFPI2 methylation in the serum of gastric cancer patients. Hibi K; Goto T; Shirahata A; Saito M; Kigawa G; Nemoto H; Sanada Y Anticancer Res; 2011 Nov; 31(11):3835-8. PubMed ID: 22110206 [TBL] [Abstract][Full Text] [Related]
6. Methylation of TFPI2 no longer detected in the serum DNA of colorectal cancer patients after curative surgery. Hibi K; Goto T; Shirahata A; Saito M; Kigawa G; Nemoto H; Sanada Y Anticancer Res; 2012 Mar; 32(3):787-90. PubMed ID: 22399594 [TBL] [Abstract][Full Text] [Related]
7. Prognostic value of circulating mutant DNA in unresectable metastatic colorectal cancer. Lefebure B; Charbonnier F; Di Fiore F; Tuech JJ; Le Pessot F; Michot F; Michel P; Frebourg T Ann Surg; 2010 Feb; 251(2):275-80. PubMed ID: 20010083 [TBL] [Abstract][Full Text] [Related]
8. Global histone modification of H3K27 correlates with the outcomes in patients with metachronous liver metastasis of colorectal cancer. Tamagawa H; Oshima T; Numata M; Yamamoto N; Shiozawa M; Morinaga S; Nakamura Y; Yoshihara M; Sakuma Y; Kameda Y; Akaike M; Yukawa N; Rino Y; Masuda M; Miyagi Y Eur J Surg Oncol; 2013 Jun; 39(6):655-61. PubMed ID: 23523318 [TBL] [Abstract][Full Text] [Related]
9. [Antioxidant status of patients with primary colorectal cancer and liver metastases of colorectal cancer]. Czeczot H; Skrzycki M; Podsiad M; Gawryszewska E; Nyckowski P; Porembska Z Pol Merkur Lekarski; 2005 Jan; 18(103):58-61. PubMed ID: 15859549 [TBL] [Abstract][Full Text] [Related]
10. Detection of SNCA and FBN1 methylation in the stool as a biomarker for colorectal cancer. Li WH; Zhang H; Guo Q; Wu XD; Xu ZS; Dang CX; Xia P; Song YC Dis Markers; 2015; 2015():657570. PubMed ID: 25802477 [TBL] [Abstract][Full Text] [Related]
11. Aberrant methylation of the HACE1 gene is frequently detected in advanced colorectal cancer. Hibi K; Sakata M; Sakuraba K; Shirahata A; Goto T; Mizukami H; Saito M; Ishibashi K; Kigawa G; Nemoto H; Sanada Y Anticancer Res; 2008; 28(3A):1581-4. PubMed ID: 18630515 [TBL] [Abstract][Full Text] [Related]
12. Methylation of TFPI2 gene is frequently detected in advanced well-differentiated colorectal cancer. Hibi K; Goto T; Kitamura YH; Yokomizo K; Sakuraba K; Shirahata A; Mizukami H; Saito M; Ishibashi K; Kigawa G; Nemoto H; Sanada Y Anticancer Res; 2010 Apr; 30(4):1205-7. PubMed ID: 20530429 [TBL] [Abstract][Full Text] [Related]
13. Quantitative detection of promoter hypermethylation in multiple genes in the serum of patients with colorectal cancer. Leung WK; To KF; Man EP; Chan MW; Bai AH; Hui AJ; Chan FK; Sung JJ Am J Gastroenterol; 2005 Oct; 100(10):2274-9. PubMed ID: 16181380 [TBL] [Abstract][Full Text] [Related]
14. Detection of hypermethylated fibrillin-1 in the stool samples of colorectal cancer patients. Guo Q; Song Y; Zhang H; Wu X; Xia P; Dang C Med Oncol; 2013 Dec; 30(4):695. PubMed ID: 23963856 [TBL] [Abstract][Full Text] [Related]
15. The FBN2 gene: new mutations, locus-specific database (Universal Mutation Database FBN2), and genotype-phenotype correlations. Frédéric MY; Monino C; Marschall C; Hamroun D; Faivre L; Jondeau G; Klein HG; Neumann L; Gautier E; Binquet C; Maslen C; Godfrey M; Gupta P; Milewicz D; Boileau C; Claustres M; Béroud C; Collod-Béroud G Hum Mutat; 2009 Feb; 30(2):181-90. PubMed ID: 18767143 [TBL] [Abstract][Full Text] [Related]
16. WNT5A gene is aberrantly methylated from the early stages of colorectal cancers. Hibi K; Mizukami H; Goto T; Kitamura Y; Sakata M; Saito M; Ishibashi K; Kigawa G; Nemoto H; Sanada Y Hepatogastroenterology; 2009; 56(93):1007-9. PubMed ID: 19760930 [TBL] [Abstract][Full Text] [Related]
18. Methylation of CLDN6, FBN2, RBP1, RBP4, TFPI2, and TMEFF2 in esophageal squamous cell carcinoma. Tsunoda S; Smith E; De Young NJ; Wang X; Tian ZQ; Liu JF; Jamieson GG; Drew PA Oncol Rep; 2009 Apr; 21(4):1067-73. PubMed ID: 19288010 [TBL] [Abstract][Full Text] [Related]
19. Aberrant methylation of the p16 gene is frequently detected in advanced colorectal cancer. Goto T; Mizukami H; Shirahata A; Sakata M; Saito M; Ishibashi K; Kigawa G; Nemoto H; Sanada Y; Hibi K Anticancer Res; 2009 Jan; 29(1):275-7. PubMed ID: 19331161 [TBL] [Abstract][Full Text] [Related]
20. Aberrant methylation of the UNC5C gene is frequently detected in advanced colorectal cancer. Hibi K; Mizukami H; Shirahata A; Goto T; Sakata M; Saito M; Ishibashi K; Kigawa G; Nemoto H; Sanada Y Anticancer Res; 2009 Jan; 29(1):271-3. PubMed ID: 19331160 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]